Research Funded to Date

2014 Awards

Career Development Award Research Projects

Career Development Awards support young researchers who will be the future leaders in lung cancer research; these are mentored awards whose research focus may be either early detection or targeted therapeutics.

Patrick FordeNeoadjuvant anti-PD-1 antibody, Nivolumab, in resectable NSCLC

Patrick Forde, MD (MB, BCh)
Johns Hopkins Kimmel Cancer Center, Baltimore, MD

 

 

Christine LovlyDissecting the role of negative feedback inhibition in ALK+ lung cancer

Christine Lovly, MD, PhD
Vanderbilt University School of Medicine, Nashville, TN

 

 

John PoirierMolecular mechanisms of acquired drug resistance in small cell lung cancer

John Poirier, PhD
Memorial Sloan-Kettering Cancer Center, New York, NY
This grant was funded in part by the American Lung Association


Early Detection Award Research Projects

Early Detection Awards support projects directed at the discovery of new approaches to improve clinical methods for the detection and diagnosis of primary tumors.

Zeynep H. GumusIdentifying germline risk mutations for early-onset and familial NSCLC

Zeynep H. Gümüş, PhD
Icahn School of Medicine at Mount Sinai, New York, NY
Steven M. Lipkin, MD, PhD
Joan & Sanford I. Weill Medical College of Cornell University, New York, NY
Kenneth Offit, MD, MPH
Memorial Sloan-Kettering Cancer Center, New York, NY

Abhijit PatelDetection of early-stage lung cancers via tumor DNA in blood

Abhijit Patel, MD, PhD
Yale University, New Haven, CT

 

 

Kimberly M. Rieger-ChristNasal biomarkers for the evaluation of lung nodules found by LDCT screening

Kimberly M. Rieger-Christ, PhD
Jacob Sands, MD
Lahey Hospital & Medical Center, Burlington, MA
Katrina Steiling, MD, MSc
Boston University, Boston, MA

Targeted Therapeutics Award Research Projects

Targeted Therapeutics Awards support projects, including immuno-oncology projects, directed at the discovery and validation of targeted therapeutics that will make a difference in the clinical treatment and survival of patients.

Alberto ChiapporiAntagonism of adenosine A2A receptor to improve lung cancer immunotherapy

Alberto Chiappori, MD
Scott Antonia, MD, PhD
H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

 

Julien SageActivating phagocytosis to inhibit small cell lung carcinoma

Julien Sage, PhD
Irving Weissman, MD
Stanford University, Stanford, CA


Alejandro Sweet-CorderoProtein engineering to target tumor-stroma interactions in NSCLC

Alejandro Sweet-Cordero, MD
Jennifer Cochran, PhD
Stanford University, Stanford, CA

 

 

Partnership Research on Treatments for Brain Metastases

LUNGevity Foundation, in partnership with the Melanoma Research Alliance and the Lung Cancer Research Foundation, is co-funding research on PD-I inhibitor treatment options for both non-small cell lung cancer (NSCLC) and metastatic melanoma (MM) patients with brain metastases.

Lucia JilaveanuResponse to PD-1 inhibitors in lung cancer and melanoma patients with brain metastases

Lucia Beatrice Jilaveanu, MD, PhD
Yale University, New Haven, CT

 

 

2013 Awards

Career Development Award Research Projects

Career Development Awards support young researchers who will be the future leaders in lung cancer research; these are mentored awards whose research focus may be either early detection or targeted therapeutics. The amounts below reflect funding for the first year of these three-year grants.

Timothy BurnsTargeting KRAS-mutant NSCLC through inhibition of MTOR and Hsp90

Timothy F. Burns, MD, PhD

Assistant Professor of Medicine
University of Pittsburgh Cancer Institute, Pittsburgh, PA

Grant: $100,000
Award Period: July 15, 2013 - July 14, 2014

David KozonoBiomarkers for NSCLC radiosensitization by proteasome inhibition

David E. Kozono, MD, PhD

Instructor in Radiation Oncology
Dana-Farber Cancer Institute, Boston, MA

Grant: $100,000
Award Period: July 15, 2013 - July 14, 2014

Meredith TennisBiomarkers for targeted lung cancer chemoprevention

Meredith Tennis, PhD

Instructor
University of Colorado Denver, Denver, CO

Grant: $100,000
Award Period: July 15, 2013 - July 14, 2014

Early Detection Award Research Projects

Early Detection Awards support projects directed at the discovery of new approaches to improve clinical methods for the detection and diagnosis of primary tumors. The amounts below reflect funding for the first year of these two-year grants.

Feng Jiang for Sept 2013 e-newsletterSputum biomarkers for the early detection of lung cancer

Feng Jiang, MD, PhD

Associate Professor, Department of Pathology
University of Maryland, Baltimore, MD

Grant: $200,000
Award Period: August 15, 2013 - August 14, 2014
This grant was funded in part by Upstage Lung Cancer

Ignacio Wistuba for Sept 2013 e-newsletterIdentification of biomarkers for the detection of small cell lung cancer

Ignacio I. Wistuba, MD

Jay and Lori Eisenberg Professor & Chair, Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center

Grant: $200,000
Award Period: August 15, 2013 - August 14, 2014

Targeted Therapeutics Award Research Projects

Targeted Therapeutics Awards support projects, including immuno-oncology projects, directed at the discovery and validation of targeted therapeutics that will make a difference in the clinical treatment and survival of patients. The amounts below reflect funding for the first year of these two-year grants.

Balazs HalmosIdentification of predictive biomarkers of chemoradiotherapy in lung cancer

Balazs Halmos, MD

Associate Professor of Clinical Medicine
Columbia University Medical Center, New York, NY

Grant: $150,000
Award Period: July 15, 2013 - July 14, 2014

Lecia SequistDetermining mechanisms of resistance to next-generation EGFR inhibitors

Lecia V. Sequist, MD

Attending Oncologist
Massachusetts General Hospital, Boston, MA

Grant: $200,000
Award Period: July 15, 2013 - July 14, 2014

Frank SlackTargeting KRAS mutations in lung cancer

Frank J. Slack, PhD

Professor
Division of Molecular, Cellular & Developmental Biology, Yale University, New Haven, CT

Grant:  $250,000
Award Period:  July 15, 2013-July 14, 2014

Special thanks to Genentech for supporting the 2013 LUNGevity Research Awards Program.


2012 Awards

Career Development Award Research Projects

The amounts below reflect funding for the first two years of these three-year grants.

Dr. Jennifer BeaneBiomarkers of pre-malignant disease progression for lung cancer detection

Jennifer Beane, PhD

Assistant Professor
Boston University, Boston, MA

Grant: $200,000
Award Period: July 15, 2012 - July 14, 2014

Dr. Lauren ByersPARP1 as a novel therapeutic target in small cell lung cancer

Lauren Byers, MD

Assistant Professor
University of Texas M.D. Anderson Cancer Center, Houston, TX

Grant: $200,000
Award Period: July 15, 2012 - July 14, 2014

Awarded with support from A Breath of Hope Lung Foundation and the Janice McArdle Cancer Research Foundation

Dr. Mohamed HassaneinDeveloping new non-invasive methods for the diagnosis of lung cancer

Mohamed Hassanein, PhD

Research Instructor
Vanderbilt University Medical Center, Nashville, TN

Grant: $200,000
Award Period: July 15, 2012 - July 14, 2014

Awarded with support from the Janice McArdle Cancer Research Foundation

Dr. Christopher MaherMolecular predictors of outcome in non-small cell lung cancer

Christopher A. Maher, PhD

Assistant Professor
Washington University in St. Louis, St. Louis, MO

Grant: $200,000
Award Period: July 15, 2012 - July 14, 2014

Selected for LUNGevity’s Melissa Lumberg Zagon Founders’ Award

Dr. Viswam NairIn-vivo and in-vitro diagnostics to improve lung cancer care

Viswam S. Nair, MD

Research Fellow
Stanford University, Stanford, CA

Grant: $200,000
Award Period: July 15, 2012 - July 14, 2014

Special thanks to Genentech for supporting the LUNGevity Career Development Awards Program.


View the archive of earlier awards